Medicines for Europe
Trending Articles
Related Content
Manufacturing
EU supply chain regulation: what will it mean for companies attending CPHI?
Ahead of her session on “Manufacturing Excellence” at CPHI Frankfurt (1–3 November), Elisabeth Stampa, President of Medicines for Europe, along with Adrian van den Hoven, Director General of Medicines for Europe, map out the impact of EU supply chain regulation on pharma companies in an exclusive article for Manufacturing Chemist
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.